(Press-News.org)
Public interest in weight loss drugs like Wegovy and Ozempic is surging, but national data on dispensing patterns in the United States are surprisingly scarce.
Now, a national study from Michigan Medicine shows that the use of these weight loss drugs is increasing rapidly in adolescents and young adults 12-25 years, especially females.
Using 2020 - 2023 data from a national database representing 92% of pharmacies, the study team found a 594% increase in the monthly number of adolescents and young adults using Wegovy, Ozempic, and other glucagon-like peptide-1 receptor agonists (GLP-1RAs).
For females, this increase was even more pronounced.
The number of female adolescents 12-17 years using GLP-1RAs increased 588%, compared with 504% for male adolescents.
The number of female young adults 18-25 years using GLP-1 RAs increased 659%, compared with 481% for male young adults.
“This is the first study to document national trends in GLP-1RA dispensing in any population, including youth, said Joyce Lee, MD, MPH, the lead author of the paper. Lee is a pediatric endocrinologist and Professor of Pediatrics in the Susan B. Meister Child Health Evaluation and Research Center at the University of Michigan Medical School, the C.S. Mott Children's Hospital, and the Caswell Diabetes Institute.
GLP-1RAs were approved for type 2 diabetes in 2005 and for weight management in 2014.
Interest in these drugs surged in 2021 when semaglutide was approved for weight management in adults under the brand name Wegovy, and increased even further when Wegovy was approved for weight management in adolescents at the end of 2022.
The report finds that endocrinologists, family medicine physicians and nurse practitioners were among the top prescribers of GLP-1 RAs to youth, suggesting that these clinicians should be the focus of efforts to ensure safe and appropriate prescribing.
For example, because the biggest usage increase occurred in females, clinicians need to educate female patients about the potential safety risks of these GLP-1 RAs during pregnancy.
The report also found that dispensing of Ozempic increased in youth, even though Ozempic is not approved in children for type 2 diabetes or weight management.
“This finding suggests increasing off-label use of Ozempic for weight management in adolescents and young adults,” said Kao-Ping Chua, MD, the senior author of the paper and a member of the CHEAR Center.
Lee adds that some concerns have been raised about both the cost of GLP-1 RAs, which are expensive and meant to be taken over the longterm, as well as the unknown effects of these drugs on growth and development in youth.
“The increasing use of GLP-1 RAs highlights the importance of understanding the long-term safety, efficacy, and cost-effectiveness of GLP-1RAs in adolescents and young adults,” she said.
Additional authors include Lauren Oshman, M.D., M.P.H., Dina H. Griauzde, M.D., MS.c.
The purchase of the IQVIA data was supported by the Susan B. Meister Child Health Evaluation and Research Center at the University of Michigan Medical School. This work was supported by grants P30DK089503 (MNORC), P30DK020572 (MDRC), and P30DK092926 (MCDTR) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Elizabeth Weiser Caswell Diabetes Institute at the University of Michigan. Dr. Chua is supported by grants R01DA057284-01 and K08DA048110-04 from the National Institute on Drug Abuse (NIDA). Dr. Sharifi’s research is supported by the National Heart, Lung, and Blood Institute (NHLBI) (R01HL151603) and the National Institute on Minority Health and Health Disparities (NIMHD) (R01MD014853) of the National Institutes of Health (NIH).
The Susan B. Meister Child Health Evaluation and Research Center, ElizabethWeiser Caswell Diabetes Institute, and the NIDDK NIDA, NHLBI, and NIMHD of the NIH had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Lee reported receiving personal fees from GoodRx, Tandem Diabetes Care, and Sanofi outside the submitted work. Oshman reported stock investment from Eli Lilly (divested 2022) and Abbott (divested 2022) outside the submitted work. Griauzde reported receiving grants from NIH/NIDDK outside the submitted work. Chua reported receiving personal fees from the Benter Foundation and US Department of Justice outside the submitted work.
Paper cited: “Dispensing of Glucagon-Like Peptide-1 Receptor Agonists to Adolescents and Young Adults, 2020-2023,” JAMA. DOI: 10.1001/jama.2024.7112
END
Reading about the latest scientific discovery – such as the unearthing of a fossil representing a new species of tiny dinosaur – can be fascinating. But what if it were possible to do more than just read about it? What if you could go online, download a digital model and 3D print an exact replica of that fossil within minutes of reading the news? That is the goal of the Non-Clinical Tomography Users Research Network, or NoCTURN, an international group of researchers spearheaded by theUniversity of Arizona Health Sciences, the American ...
Autism is the most common neurodevelopmental disorder in the U.S., affecting an estimated one out of 36 children. Most people with autism experience unique sensory features such as differences in reactivity to touch, sounds, and sights or difficulty managing multiple sensory inputs at the same time.
These sensory differences can make the healthcare environment — often characterized by fluorescent lights, idle waiting rooms and uncomfortable pokes and prods — difficult to navigate, preventing children with autism from getting the care they need. To change that, occupational therapists Roseann ...
Medical procedures capable of moving cells inside the body without making incisions have unique benefits. From faster recovery times to less trauma impacting the body, the list of reasons to do surgery without scalpels is growing with the technology used to perform noninvasive treatments.
A new method that might be available in the future is coming to life through research conducted by Zhenhua Tian’s team. The assistant professor in the Department of Mechanical Engineering is using tube-shaped acoustic energy to capture tiny biological ...
TORONTO, May 22, 2024 – Community science volunteers – laypeople with an interest in bees and conservation – significantly contribute to the scientific knowledge of native bumble bees across Canada and the United States, finds a new study by York University.
It’s buzz worthy confirmation that community science programs can play an important role in monitoring the changing distributions of bumble bees and more. Community scientists have importantly also detected several at-risk or endangered species in unexpected locations, including the rusty-patched bumble bee and the gypsy cuckoo bumble bee. Trained scientists often haven’t seen some ...
Location, race and insurance status play a significant part in the odds of a patient being diagnosed with early-stage or late-stage cancer, according to a detailed medical records analysis of more than 94,000 patients with cancer by researchers at the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center.
Patients who lived farther away from a facility designated a comprehensive cancer center (CCC) by the National Cancer Institute (NCI) and who received only a diagnosis or only treatment at the center had higher than average odds of a late-stage diagnosis, ...
Surgery involving sentinel lymph node biopsy for middle-aged women with estrogen receptor-positive (ER+) breast cancer may do more harm than good, according to a new study led by University of Pittsburgh and UPMC Hillman Cancer Center researchers. The team used a novel artificial intelligence pipeline developed by Realyze Intelligence, a UPMC Enterprises portfolio company, to analyze electronic health records.
The findings, published today in JCO Clinical Cancer Informatics, suggest that clinical guidelines for de-escalating surgery in women aged over 70 years with early-stage ER+ breast cancer may be safely ...
MINNEAPOLIS – People who eat more ultra-processed foods like soft drinks, chips and cookies may have a higher risk of having memory and thinking problems and having a stroke than those who eat fewer processed foods, according to a new study published in the May 22, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that eating ultra-processed foods causes memory and thinking problems and stroke. It only shows an association.
Ultra-processed foods are high in added sugar, fat and salt, and low in protein and fiber. They include soft drinks, salty and sugary snacks, ...
MINNEAPOLIS – What factors lead older adults to stop driving? A new study followed older adults who had no memory or thinking problems to examine this question. The study is published in the May 22, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
“Alzheimer’s disease develops over a long time—people may have a 10- to 15-year period where they have no symptoms, but the disease process is developing in the brain,” said study author Ganesh M. Babulal, PhD, OTD, of Washington University School of Medicine in St. ...
One of the thorniest decisions facing older adults is when to give up their keys and stop driving. A new study by researchers at Washington University School of Medicine in St. Louis could provide guidance in helping seniors plan ahead. The researchers found that impaired cognitive function foreshadows the decision for many seniors to stop driving — more so than age or molecular signs of Alzheimer’s disease. Even very slight cognitive changes are a sign that retirement from driving is imminent. Further, women are more likely to stop driving than ...
May 22, 2024 – Irina Petrache, MD, ATSF, today added president of the American Thoracic Society to her list of accomplishments. The announcement came on the heels of the Plenary Session at the ATS 2024 International Conference. The slate of officers to serve on the Society’s Executive Committee for the 2024-2025 term consists of the following:
Irina Petrache, MD, ATSF, Incoming President
Dr. Petrache is professor of medicine at National Jewish Health and at the University of Colorado. She also serves as chief of Pulmonary, Critical Care and Sleep Medicine, associate ...
